News & Updates

Treatment outcomes for patients with high-risk neuroblastoma in Southeast Asia are poor all in all, but intensified medical and surgical procedures appear effective at improving survival rates, according to a study in Singapore.

Complex chronic conditions (CCCs) in children are associated with numerous brief hospitalizations, with a high rate of readmissions, according to a study presented at PAS 2023.

Patients with resected Crohn’s disease (CD) who were treated with the gut-selective α4β7-integrin inhibitor vedolizumab were less likely to have endoscopic signs of recurrence compared with placebo in the Reprevio study presented at DDW 2023.

Use of a breathing retraining biofeedback device has been shown to ameliorate panic symptoms in children, particularly among those aged 13 to 17 years, reports a study presented at PAS 2023.

Use of ustekinumab for up to 4 years in paediatric patients with Crohn’s disease (CD) shows similar efficacy, safety, pharmacokinetics (PK), and immunogenicity to that seen in adult patients, according to the results of the UniStar study long-term extension.